Aksan has advised PhiTech Bioinformatics on receiving an investment from the Maxis Arya venture capital fund.
PhiTech Bioinformatics translates genome-wide molecular data into biotechnology solutions primarily for use in precision medicine.
The Aksan team included Partner Alper Onar, Senior Associate Merve Kutukcuoglu Karpuzcu, and Associate Betul Colak.
Aksan did not respond to our inquiry on the matter.